Ronen Israel

Ronen Israel’s primary focus is on portfolio management and research at AQR. He was instrumental in helping to build AQR’s Global Stock Selection group and its initial algorithmic trading capabilities, and now runs the Global Alternative Premia group, which employs various investing styles across asset classes. He is on the executive board of the University of Pennsylvania’s Jerome Fisher Program in Management and Technology and is a member of the Advisory Board of The Rodney L. White Center for Financial Research, The Wharton School, University of Pennsylvania. Prior to AQR, he was a senior analyst at Quantitative Financial Strategies Inc. Israel earned a B.S. in economics from the Wharton School at the University of Pennsylvania, a B.A.S. in biomedical science from the University of Pennsylvania’s School of Engineering and Applied Science, and an M.A. in mathematics, specialising in mathematical finance, from Columbia.

Education

• M.A., Mathematics, 2000 Columbia University
• B.A.S., Biomedical Science, 1995 University of Pennsylvania, School of Engineering
• B.S., Economics, 1995 University of Pennsylvania, Wharton School

Companies

• Board Member Protean BioDiagnostics (2022)
• Advisory Board Member Center for Innovation & Precision Dentistry (CiPD), University of Pennsylvania (2022)
• Senior Advisor AQR Capital Management (2022)
• Adjunct Professor Yale School of Management (2021)
• Cofounder BioConvergent Health (2021)
• Board Member CNH Finance (2018)
• Advisory Board Member The Rodney L. White Center for Financial Research (2017)
• Adjunct Professor NYU Stern School of Business (2014)
• Executive Board Member Jerome Fisher M&T Program (2010)